Recent publications · Crossref
5 total works indexed
- Osimertinib in Untreated
<i>EGFR</i>
-Mutated Advanced Non–Small-Cell Lung Cancer
· 2018 · cited 4,721x
- Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
· 2010 · cited 3,273x
- The Global Methane Budget 2000–2017
· 2020 · cited 2,128x
- Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
· 2019 · cited 1,949x
- Expanded graphite as superior anode for sodium-ion batteries
· 2014 · cited 1,816x
via Crossref · CC0